• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全球癌症发病率和死亡率数据2020版年龄标准化世界估计值对癌症参数进行建模。

Modelling incidence and mortality cancer parameters with respect to GLOBOCAN 2020Age standardized world estimates.

作者信息

Acquah Joseph, Bosson-Amedenu Senyefia, Eyiah-Bediako Francis, Buabeng Albert, Ouerfelli Noureddine

机构信息

Mathematical Sciences Department, University of Mines and Technology, Tarkwa, Ghana.

Department of Mathematics, Statistics and Actuarial Science, Takoradi Technical University, Takoradi, Ghana.

出版信息

Heliyon. 2024 Aug 25;10(17):e36836. doi: 10.1016/j.heliyon.2024.e36836. eCollection 2024 Sep 15.

DOI:10.1016/j.heliyon.2024.e36836
PMID:39263161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11388729/
Abstract

In this paper, an empirical model with the critical number of incidences and deaths for female cancers as adjustable parameters has been developed using life expectancy data from GLOBOCAN world estimates on cancer types. The model was developed based on the cumulative risk and exponential correlation techniques such that the significance of the adjustable parameters ascertains the strength of this research in two ways. First, it indicates indicates the rapid increase in female cancer morbidity with increase in the number of male cancer cases, regardless of incidence or mortality. Second, it suggests that female cancer cases may approach a virtual limiting value as male cancer cases reach extremely high levels. This projection aligns with the global population trends, indicating a proportional increase in cancer cases each year. Additionally, the cumulative risk of cancer incidences of each sex has been modelled separately against the global cumulative risk of cancer incidences of both sexes which revealed regions that have passed their inflection point and those that are yet to reach the inflection point. There was a curvature change, which indicates an inflection point coinciding with the South-Eastern Region and indicating that for the regions beyond the inflection point, the increase of the cumulative risk of cancer incidences of females against that of males is more accentuated compared with the regions before the inflection point. However, when the cumulative risk of cancer mortality of each sex is modelled separately against the global cumulative risk of cancer mortality of both sexes shows a non-linear dependence and the increase is more accentuated for males than for females. This finding indicates that cumulative risk is influenced by factors beyond the male-female population ratio. This study advances cancer studies as it provides a nuanced understanding of gender-specific cancer trends, crucial for developing targeted cancer prevention and treatment strategies. By elucidating the dynamics of cancer incidences and mortalities across different regions and sexes, the findings can inform public health policies and resource allocation to combat cancer more effectively on a global scale.

摘要

在本文中,利用来自全球癌症负担估计(GLOBOCAN)关于癌症类型的世界估计中的预期寿命数据,开发了一个以女性癌症发病和死亡的临界数量为可调参数的实证模型。该模型基于累积风险和指数相关技术开发,使得可调参数的重要性从两个方面确定了本研究的力度。首先,它表明随着男性癌症病例数的增加,女性癌症发病率迅速上升,无论发病率还是死亡率都是如此。其次,它表明随着男性癌症病例数达到极高水平,女性癌症病例可能接近一个虚拟的极限值。这一预测与全球人口趋势一致,表明每年癌症病例数成比例增加。此外,还分别针对两性癌症发病率的全球累积风险对每种性别的癌症发病率累积风险进行了建模,这揭示了已经过拐点的地区和尚未达到拐点的地区。存在曲率变化,这表明拐点与东南部地区重合,并且表明对于拐点之后的地区,女性癌症发病率累积风险相对于男性的增加比拐点之前的地区更为明显。然而,当分别针对两性癌症死亡率的全球累积风险对每种性别的癌症死亡率累积风险进行建模时,显示出非线性依赖性,并且男性的增加比女性更为明显。这一发现表明累积风险受到男女人口比例之外的因素影响。这项研究推动了癌症研究,因为它提供了对特定性别癌症趋势的细致理解,这对于制定有针对性的癌症预防和治疗策略至关重要。通过阐明不同地区和性别的癌症发病率和死亡率动态,这些发现可为公共卫生政策和资源分配提供信息,以便在全球范围内更有效地抗击癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/fe212760b010/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/dd1a85ab86d6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/622c3e54878f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/dcf1e70fbe82/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/6c810bc120be/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/46247d79edf8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/ee5aecf6fbaa/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/122323b2aac8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/523959001010/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/fe212760b010/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/dd1a85ab86d6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/622c3e54878f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/dcf1e70fbe82/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/6c810bc120be/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/46247d79edf8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/ee5aecf6fbaa/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/122323b2aac8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/523959001010/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/466f/11388729/fe212760b010/gr9.jpg

相似文献

1
Modelling incidence and mortality cancer parameters with respect to GLOBOCAN 2020Age standardized world estimates.基于全球癌症发病率和死亡率数据2020版年龄标准化世界估计值对癌症参数进行建模。
Heliyon. 2024 Aug 25;10(17):e36836. doi: 10.1016/j.heliyon.2024.e36836. eCollection 2024 Sep 15.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].[国家重点污染场地居民流行病学研究。第六次报告]
Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003.
4
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
5
Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022.癌症发病率和死亡率的社会经济不平等:基于 GLOBOCAN 2022 的分析。
Chin Med J (Engl). 2024 Jun 20;137(12):1407-1413. doi: 10.1097/CM9.0000000000003140. Epub 2024 Apr 15.
6
Tuberculosis结核病
7
Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.2012 年全球 20-39 岁年轻人癌症发病率和死亡率:一项基于人群的研究。
Lancet Oncol. 2017 Dec;18(12):1579-1589. doi: 10.1016/S1470-2045(17)30677-0. Epub 2017 Oct 27.
8
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
9
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率,1990-2013 年:2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
10
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.

本文引用的文献

1
Natural and synthetic nanovectors for cancer therapy.用于癌症治疗的天然和合成纳米载体。
Nanotheranostics. 2023 Mar 5;7(3):236-257. doi: 10.7150/ntno.77564. eCollection 2023.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Evaluating the effectiveness of a group-based resilience intervention versus psychoeducation for emergency responders in England: A randomised controlled trial.
评估英格兰基于小组的韧性干预措施与心理教育对急救人员的效果:一项随机对照试验。
PLoS One. 2020 Nov 12;15(11):e0241704. doi: 10.1371/journal.pone.0241704. eCollection 2020.
4
The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network.撒哈拉以南非洲地区乳腺癌流行趋势的演变:来自非洲癌症登记网络的结果。
Int J Cancer. 2020 Oct 15;147(8):2131-2141. doi: 10.1002/ijc.33014. Epub 2020 Apr 30.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
7
Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends.非洲、拉丁美洲和加勒比以及亚洲的宫颈癌:区域不平等和变化趋势。
Int J Cancer. 2017 Nov 15;141(10):1997-2001. doi: 10.1002/ijc.30901. Epub 2017 Aug 10.
8
Global Cancer in Women: Burden and Trends.全球女性癌症:负担与趋势
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457. doi: 10.1158/1055-9965.EPI-16-0858. Epub 2017 Feb 21.
9
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年79种行为、环境与职业及代谢风险或风险群组的全球、区域和国家比较风险评估:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
10
Prostate cancer burden in Central and South America.中美洲和南美洲的前列腺癌负担。
Cancer Epidemiol. 2016 Sep;44 Suppl 1:S131-S140. doi: 10.1016/j.canep.2016.06.010.